ATE82134T1 - Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens. - Google Patents

Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.

Info

Publication number
ATE82134T1
ATE82134T1 AT88401996T AT88401996T ATE82134T1 AT E82134 T1 ATE82134 T1 AT E82134T1 AT 88401996 T AT88401996 T AT 88401996T AT 88401996 T AT88401996 T AT 88401996T AT E82134 T1 ATE82134 T1 AT E82134T1
Authority
AT
Austria
Prior art keywords
polyosides
strains
staphylococcus
capsules
recovering
Prior art date
Application number
AT88401996T
Other languages
German (de)
English (en)
Inventor
Jean-Michel Fournier
Anne Bouvet
Alain Boutonnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE82134T1 publication Critical patent/ATE82134T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/883—Staphylococcus aureus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88401996T 1987-08-03 1988-07-29 Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens. ATE82134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8711006A FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
EP88401996A EP0302781B1 (fr) 1987-08-03 1988-07-29 Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé

Publications (1)

Publication Number Publication Date
ATE82134T1 true ATE82134T1 (de) 1992-11-15

Family

ID=9353830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88401996T ATE82134T1 (de) 1987-08-03 1988-07-29 Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.

Country Status (11)

Country Link
US (1) US4902616A (OSRAM)
EP (1) EP0302781B1 (OSRAM)
JP (1) JPH01128793A (OSRAM)
AT (1) ATE82134T1 (OSRAM)
CA (1) CA1320466C (OSRAM)
DE (1) DE3875850T2 (OSRAM)
DK (1) DK173564B1 (OSRAM)
ES (1) ES2052759T3 (OSRAM)
FR (1) FR2619122B1 (OSRAM)
GR (1) GR3006613T3 (OSRAM)
PT (1) PT88166B (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
GB8906794D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Preparation of vaccines
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
CA2123811C (en) * 1991-11-22 2005-07-05 Ali Ibrahim Fattom Type i and type ii surface antigens associated with staphylococcus epidermidis
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US5837482A (en) * 1997-01-23 1998-11-17 Minnesota Mining And Manufacturing Company Culture medium and methods for detecting staphylococci
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
WO2000003745A2 (en) * 1998-07-15 2000-01-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6936258B1 (en) * 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
AU2002303832A1 (en) * 2001-05-21 2002-12-03 Beth Israel Deaconess Medical Center, Inc. P.aeruginosa mucoid exopolysaccharide specific binding peptides
MXPA05005045A (es) 2002-11-12 2005-07-01 Brigham & Womens Hospital Vacuna de polisacarido para infecciones estafilococicas.
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
KR20070001935A (ko) * 2003-12-30 2007-01-04 쓰리엠 이노베이티브 프로퍼티즈 컴파니 세포의 세포벽 성분의 시그날 검출을 증진시키는 방법
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
WO2005103084A2 (en) 2004-04-21 2005-11-03 The Brigham And Women's Hospital, Inc. Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
CA2581330A1 (en) * 2004-09-21 2006-03-30 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
JP5658564B2 (ja) * 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
NZ591103A (en) 2008-07-21 2013-02-22 Brigham & Womens Hospital Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
US8758765B2 (en) * 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
EP3281947B1 (en) 2009-04-03 2020-02-12 The University of Chicago Compositions and methods related to protein a (spa) variants
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
JP5944480B2 (ja) * 2011-03-22 2016-07-05 セルム・インスティテュート・オブ・インディア・ピーブイティー．・リミテッド 多糖を調製するための新規な方法
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
AU2020273471B2 (en) 2019-05-14 2026-05-07 The University Of Chicago Methods and compositions comprising Staphylococcus protein A (SpA) variants
US12528882B2 (en) 2019-09-13 2026-01-20 The University Of Chicago Methods and compositions for treating staphylococcal infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Also Published As

Publication number Publication date
DK433488A (da) 1989-02-04
DK433488D0 (da) 1988-08-03
DE3875850T2 (de) 1993-06-09
EP0302781B1 (fr) 1992-11-11
CA1320466C (en) 1993-07-20
FR2619122A1 (fr) 1989-02-10
JPH01128793A (ja) 1989-05-22
PT88166A (pt) 1989-06-30
ES2052759T3 (es) 1994-07-16
GR3006613T3 (OSRAM) 1993-06-30
US4902616A (en) 1990-02-20
DE3875850D1 (de) 1992-12-17
DK173564B1 (da) 2001-03-12
FR2619122B1 (fr) 1990-03-09
EP0302781A1 (fr) 1989-02-08
PT88166B (pt) 1995-07-03

Similar Documents

Publication Publication Date Title
DE3875850D1 (de) Verfahren zur gewinnung von polyosiden aus staphylokokken-kapseln sowie verwendungen dieser polyoside und staemme fuer die durchfuehrung dieses verfahrens.
NL189128C (nl) Werkwijze voor de bereiding van 1,2,4-triazoolverbindingen, werkwijze voor de bereiding van preparaten voor de bestrijding van fungi die deze verbindingen bevatten, alsmede werkwijze voor het bestrijden van planteziekten.
DE3887232D1 (de) Verfahren zur Herstellung von Bildsensorbauelementen, die zu Modulen zusammengesetzt werden.
IT1193874B (it) Procedimento per la preparazione di una miscela polimerica,prodotti formati e lega polimerica ottenuti da essa
NL7611434A (nl) Werkwijze voor de bereiding van thermoplastische alkeenelastomeren, alsmede gevormde voortbreng- sels die deze elastomeren bevatten.
PT68066A (de) Verfahren zur herstellung von abformmaterialien insbesondere fur die zahnheilkunde.
NL300093I1 (nl) Werkwijze voor de bereiding van organische oligosacchariden die met fragmenten van natuurlijke mucopolysacchariden overeenkomen, de aldus verkregen oligosacchariden en hun biologische toepassing.
RU93051352A (ru) Замещенные производные циклогексана, способ их получения и применение соединений для лечения заболеваний
NL7903400A (nl) Werkwijze voor de bereiding van alpha,beta-onverzadigde n-gesubstitueerde carbonzuuramiden.
EP0137193A3 (de) Chromonalkaloid, Verfahren zu seiner Isolierung aus Dysoxylum Binectariferum, und seine Verwendung als Arzneimittel
ES498476A0 (es) Procedimiento de preparacion de arn ribosomales bacterianos
DE69013092D1 (de) Verfahren zur Isolation von Hydroxyfettsäurederivaten aus Convolvulaceae-Pflanzen.
NL7604298A (nl) Werkwijze en inrichting voor de continue vervaar- diging van gestandaardiseerde melk, evenals ge- standaardiseerde melk vervaardigd volgens de werkwijze.
NL183357B (nl) (2.3-dihydro-2.2-dimethyl-benzofuran-7-yloxy-n-methylcarbamoyl)-(n'-alkylcarbamoyl)-sulfiden, werkwijze voor de bereiding daarvan, werkwijze voor de bereiding van een insecticide preparaat alsmede werkwijze voor de bestrijding van insecten.
NL7815008A (nl) Werkwijze voor de vervaardiging van hydrofiele draden en vezels volgens de droog-mondstuk-natspinmethode.
NL7500785A (nl) Werkwijze voor de bereiding van nieuwe carbonzu- ren en derivaten daarvan, werkwijze voor de be- reiding van farmaceutische preparaten die deze nieuwe verbindingen bevatten, alsmede farmaceu- tische preparaten verkregen volgens deze werk- wijze.
NL149485B (nl) Werkwijze voor de bereiding van 5h-dibenzo (a,d) cyclohepteen-5-carbonamiden en 10, 11-dihydro-5h-dibenzo (a,d)-cyclohepteen-5-carbonamiden, een werkwijze voor de bereiding van een geneesmiddel met anti-aritmische en anti-hypertensieve werking, alsmede een dergelijk geneesmiddel.
NL191327C (nl) Hooimachine, die via een koppelbok met de driepuntsophanging van een trekker koppelbaar is.
EP0302303A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
NL7613318A (nl) Werkwijze voor de bereiding van nieuwe n-gesubsti- tueerde pyrrolidoncarbonzuren, werkwijze voor de bereiding van therapeutische preparaten die deze nieuwe verbindingen bevatten, alsmede gevormd the- rapeutisch preparaat verkregen volgens deze werkwijze.
NL7600204A (nl) Werkwijze voor de bereiding van 6,11-dihydro-11- -oxydibenz (b,e) oxepinalkaanzuren.
NL7702307A (nl) Werkwijze ter bereiding van optisch actieve erythro-15,16-dioxyprosteenzuren en esters daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve componenten om- vatten.
NL181358C (nl) Werkwijze voor de bereiding van 3,6-dichloorpicolinezuur.
IT7820129A0 (it) 2,4-diclorofenti-imidazolil-etanoni (oli), procedimento per la loro preparazione e loro impiego come prodotti medicinali.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee